Empowered Patient Podcast

Francesca Rinaldo MD Ph.D. is the Director of Clinical Quality and Innovation at Sharecare, a health and wellness engagement platform. Their SmartOmix solution allows researchers to build, launch, manage and analyze data from clinical studies using a participant-centric mobile application that leverages all the technological components of a smartphone including text-based reporting, photo, video, and audio samples.

Francesca explains, "So, in my opinion, the future of clinical research is really three things: it's decentralized, it's digital-first, and it's widely inclusive. So, I think technology will impact researchers, patients, and doctors and a number of different ways. It will impact researchers because it will give them access to data that will provide a much more comprehensive view of health and wellness, as well as how disease trajectories change for study participants."

"It will also impact patients because it will accelerate the cycle from research to care, fast-track insights, and novel approaches to therapy or new drugs into the system for participants. And as we said before, it will also decrease many barriers for patients to participate in clinical research and increase the validity of the evidence generated because the research will be conducted in much more diverse populations of patients."

@SharecareInc #Sharecare #AI #ClinicalResearch #FutureisDigitalHealth #FutureofHealthcare #FutureofClinicalResearch #AIinHealth #TechinHealthcare #VirtualCare #Telemedicine #PatientCentric #HybridHealthcare #AllTogetherBetter

Sharecare.com

Listen to the podcast here

Francesca Rinaldo MD Ph.D. is the Director of Clinical Quality and Innovation at Sharecare, a health and wellness engagement platform. Their SmartOmix solution allows researchers to build, launch, manage and analyze data from clinical studies using a participant-centric mobile application that leverages all the technological components of a smartphone including text-based reporting, photo, video, and audio samples.

Francesca explains, "So, in my opinion, the future of clinical research is really three things: it's decentralized, it's digital-first, and it's widely inclusive. So, I think technology will impact researchers, patients, and doctors and a number of different ways. It will impact researchers because it will give them access to data that will provide a much more comprehensive view of health and wellness, as well as how disease trajectories change for study participants."

"It will also impact patients because it will accelerate the cycle from research to care, fast-track insights, and novel approaches to therapy or new drugs into the system for participants. And as we said before, it will also decrease many barriers for patients to participate in clinical research and increase the validity of the evidence generated because the research will be conducted in much more diverse populations of patients."

@SharecareInc #Sharecare #AI #ClinicalResearch #FutureisDigitalHealth #FutureofHealthcare #FutureofClinicalResearch #AIinHealth #TechinHealthcare #VirtualCare #Telemedicine #PatientCentric #HybridHealthcare #AllTogetherBetter

Sharecare.com

Download the transcript here

Sam Meraj is the Senior Director of Quality, Safety, and Reporting at Walmart, including their in-store pharmacies, optical, primary care, dental, and other health services.

Sam explains, " We do keep in mind the social determinants of health. We provide a lot of linguistic support, language translation services, and we always keep health equity in mind when we are providing these services."

"I think a lot is being done to address health equity, but yet we have an opportunity to do a lot more. In terms of addressing the language barriers that I was talking about or the cultural barriers to continued education, one thing to keep in mind is that negative experiences with healthcare are unfortunately more common in these groups. And some social determinants of health, again, have historically made it difficult for them to have equal access to healthcare. So I think that it's important for individual providers as well as systems to be aware and intentional about addressing these gaps and sharing the right information to build trust and address some of these disparities."

#Walmart #SDOH #SocialDeterminantsofHealth #HealthEquity #COVID19 #PopulationHealth

Walmart.com

Listen to the podcast here

Sam Meraj is the Senior Director of Quality, Safety, and Reporting at Walmart, including their in-store pharmacies, optical, primary care, dental, and other health services.

Sam explains, " We do keep in mind the social determinants of health. We provide a lot of linguistic support, language translation services, and we always keep health equity in mind when we are providing these services."

"I think a lot is being done to address health equity, but yet we have an opportunity to do a lot more. In terms of addressing the language barriers that I was talking about or the cultural barriers to continued education, one thing to keep in mind is that negative experiences with healthcare are unfortunately more common in these groups. And some social determinants of health, again, have historically made it difficult for them to have equal access to healthcare. So I think that it's important for individual providers as well as systems to be aware and intentional about addressing these gaps and sharing the right information to build trust and address some of these disparities."

#Walmart #SDOH #SocialDeterminantsofHealth #HealthEquity #COVID19 #PopulationHealth

Walmart.com

Download the transcript here

Ali Dianaty is Vice President of Product Innovation at Medtronic Diabetes and reflects on the explosion of developments for treating diabetes that has allowed patients to manage their diabetes in a way that fits their lifestyle.

Ali explains, "We also make smart insulin pens, which allow people to do a better job of dosing their insulin. Of course, one of the big fears is that insulin can be a very dangerous drug. Think of it as if you give yourself too much, you can put yourself into harm's way. If you don't give yourself enough, it's the same thing. So, dosing that properly is super important."

"We offer pumps that help do that more automatically, as well, in terms of dosing that insulin. And then, we also offer continuous glucose monitors that measure how much glucose is in someone's body. Then ultimately, we bring all of that together into some sophisticated algorithms as a system to automatically dose people's insulin. So again, with the premise of forgetting their disease. All of these things are intended to try to minimize the work going into managing diabetes, and quite frankly, to make things easier for them."

@MDT_Diabetes #Medtronic #Diabetes #t1d #t2d #Diabetestech #DiabetesManagement #Type1 #InsulinPump #CGM #medtech

MedtronicDiabetes.com

Listen to the podcast here

Ali Dianaty is Vice President of Product Innovation at Medtronic Diabetes and reflects on the explosion of developments for treating diabetes that has allowed patients to manage their diabetes in a way that fits their lifestyle.

Ali explains, "We also make smart insulin pens, which allow people to do a better job of dosing their insulin. Of course, one of the big fears is that insulin can be a very dangerous drug. Think of it as if you give yourself too much, you can put yourself into harm's way. If you don't give yourself enough, it's the same thing. So, dosing that properly is super important."

"We offer pumps that help do that more automatically, as well, in terms of dosing that insulin. And then, we also offer continuous glucose monitors that measure how much glucose is in someone's body. Then ultimately, we bring all of that together into some sophisticated algorithms as a system to automatically dose people's insulin. So again, with the premise of forgetting their disease. All of these things are intended to try to minimize the work going into managing diabetes, and quite frankly, to make things easier for them."

@MDT_Diabetes #Medtronic #Diabetes #t1d #t2d #Diabetestech #DiabetesManagement #Type1 #InsulinPump #CGM #medtech

MedtronicDiabetes.com

Download the transcript here

Dr. Heidi Jannenga PT, DPT, ACT, is the Co-Founder and Chief Clinical Officer at WebPT. She points out that healthcare providers should be more aware of the benefits of physical therapy and how technology and telehealth are making PT more accessible for a broader audience.

Heidi explains. "This past year, with the whole COVID thing that's going on and continues to go on, we also launched a virtual visit platform. We can do telehealth with patients while they're at home so that it doesn't always have to mean that you have to get yourself to a clinic, especially those in rural areas and such. It really now has expanded our reach in terms of connecting with more patients who could benefit from physical therapist care.

"I think that it's going to take a little while for us to find the happy medium between in-person visits and virtual. By no means do I think that 100% of care from a physical therapist can be done virtually because of the nature of our clinical expertise."

@WebPT #PT #PhysicalTherapy #RehabTherapy #Telehealth #COVID19

WebPT.com

Listen to the podcast here

Dr. Heidi Jannenga PT, DPT, ACT, is the Co-Founder and Chief Clinical Officer at WebPT. She points out that healthcare providers should be more aware of the benefits of physical therapy and how technology and telehealth are making PT more accessible for a broader audience.

Heidi explains. "This past year, with the whole COVID thing that's going on and continues to go on, we also launched a virtual visit platform. We can do telehealth with patients while they're at home so that it doesn't always have to mean that you have to get yourself to a clinic, especially those in rural areas and such. It really now has expanded our reach in terms of connecting with more patients who could benefit from physical therapist care.

"I think that it's going to take a little while for us to find the happy medium between in-person visits and virtual. By no means do I think that 100% of care from a physical therapist can be done virtually because of the nature of our clinical expertise."

@WebPT #PT #PhysicalTherapy #RehabTherapy #Telehealth #COVID19

WebPT.com

Download the transcript here

Dr. Harvey Kaufman is the Senior Medical Director at Quest Diagnostics and has recently published a study on cancer diagnoses during the pandemic. Data points to a significant impact of COVID-19 on the rate of cancer screenings and the need to better identify those most at risk for a wide range of cancers.

Harvey explains, "There's a couple of things that we can do differently. One is we learned through the pandemic, the power of telemedicine, that we can do a lot of things through Zoom, and even without the visual, we can do the audio portion and engage people in questionnaires and asking about their health and such."

"We can't do certain things remotely like a mammogram or a colonoscopy or biopsies and other procedures, but there are things that we can do. We can try to identify people who are at higher risk and prioritize them over other individuals. If we don't re-engage in healthcare, there will be more and more people who will present at more advanced stages, require more aggressive therapy, and have a higher rate of death."

@QuestDX #QuestDiagnostics #cancer #CancerAwareness #COVID19 #CancerDiagnosis #ReturntoCare #CancerScreening

QuestDiagnostics.com

Listen to the podcast here

Dr. Harvey Kaufman is the Senior Medical Director at Quest Diagnostics and has recently published a study on cancer diagnoses during the pandemic. Data points to a significant impact of COVID-19 on the rate of cancer screenings and the need to better identify those most at risk for a wide range of cancers.

Harvey explains, "There's a couple of things that we can do differently. One is we learned through the pandemic, the power of telemedicine, that we can do a lot of things through Zoom, and even without the visual, we can do the audio portion and engage people in questionnaires and asking about their health and such."

"We can't do certain things remotely like a mammogram or a colonoscopy or biopsies and other procedures, but there are things that we can do. We can try to identify people who are at higher risk and prioritize them over other individuals. If we don't re-engage in healthcare, there will be more and more people who will present at more advanced stages, require more aggressive therapy, and have a higher rate of death."

@QuestDX #QuestDiagnostics #cancer #CancerAwareness #COVID19 #CancerDiagnosis #ReturntoCare #CancerScreening

QuestDiagnostics.com

Download the transcript here